HSE spent €2.5m last year on ADHD medication, figures reveal

The HSE paid out almost €2.5m on drugs to counter ADHD last year, according to new figures.

Information provided by the HSE under the Freedom of Information Act show that in 2012, the HSE paid a total of €2,482,219 on five different types of medication for Attention Deficit Hyperactivity Disorder.

The drugs for those under 18 years were paid for under three separate schemes: